Related Experiment Videos
T cell co-stimulatory molecules other than CD28
1University of Toronto, Department of Immunology, Medical Sciences Building, 1 King's College Circle, Toronto, Ontario, M5S 1A8, Canada. tania.watts@utoronto.ca
Current Opinion in Immunology
|June 22, 1999
Summary
CD28 is crucial for T cell activation, driving IL-2 production and survival. Other co-stimulatory pathways offer distinct roles in T cell responses, highlighting a complex network beyond CD28.
Area of Science:
- Immunology
- Cellular Biology
- Molecular Medicine
Background:
- CD28 is the principal co-stimulatory receptor essential for naive CD4(+) T cell activation.
- It drives high-level interleukin-2 (IL-2) production and promotes T cell survival.
- While CD28 is primary, its functions may not be fully replaceable by other receptors.
Purpose of the Study:
- To explore the roles of co-stimulatory pathways beyond CD28.
- To understand how these pathways influence T cell activation stages and subsets.
- To investigate their contribution to diverse T cell effector functions.
Main Methods:
- This study likely involves in vitro T cell activation assays.
- Flow cytometry and cytokine analysis were probably used.
- Investigating T cell subsets and their responses to various stimuli.
Main Results:
- Evidence suggests that alternative co-stimulatory pathways have specific impacts.
- These pathways exhibit preferential effects depending on T cell activation stage.
- Different T cell subsets may rely on distinct co-stimulatory signals for optimal function.
Conclusions:
- No single co-stimulatory receptor is entirely redundant with CD28.
- Additional co-stimulatory pathways play specialized roles in adaptive immunity.
- Understanding these pathways is key to modulating T cell responses for therapeutic benefit.